| 发明名称 |
Solid oral dosage forms of valsartan |
| 摘要 |
The present invention is concerned with solid oral dosage forms of comprisinga) an active agent selected from valsartan and optionally HCTZ, andb) Pharmaceutically acceptable additives suitable for the preparation of solid oral dosage forms by compression methods.
|
| 申请公布号 |
US6858228(B2) |
申请公布日期 |
2005.02.22 |
| 申请号 |
US20020251009 |
申请日期 |
2002.09.20 |
| 申请人 |
NOVARTIS AG |
发明人 |
KATAKUSE YOSHIMITSU;KOHLMEYER MANFRED;TAIKE TAKASHI;WAGNER ROBERT FRANK;YAMATO FUJIKI |
| 分类号 |
A61K9/16;A61K9/20;A61K31/41;A61K31/54;A61K31/549;A61K47/04;A61K47/12;A61K47/26;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61P3/10;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P13/12;A61P21/00;A61P25/04;A61P25/28;(IPC1-7):A61K9/20 |
主分类号 |
A61K9/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
